These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8667626)
1. Improvement of pharmacokinetics and antitumor activity against human hepatoma cell line by using adriamycin-entrapped stealth liposomes. Shimizu H; Kumai K; Uyama I; Shibata S; Tagawa T; Nagaike K; Yasuda T; Kitajima M; Tadakuma T J Surg Oncol; 1996 Jul; 62(3):186-93. PubMed ID: 8667626 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody. Konno H; Suzuki H; Tadakuma T; Kumai K; Yasuda T; Kubota T; Ohta S; Nagaike K; Hosokawa S; Ishibiki K Cancer Res; 1987 Aug; 47(16):4471-7. PubMed ID: 2440568 [TBL] [Abstract][Full Text] [Related]
3. [Experimental studies on targeting chemotherapy using adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody]. Suzuki H Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):257-65. PubMed ID: 1711147 [TBL] [Abstract][Full Text] [Related]
4. [Importance of the conjugated antibody for the induction of selective effect of adriamycin conjugated with anti AFP monoclonal antibody and entrapped in liposomes against AFP producing tumors]. Konno H; Kumai K; Tsubouchi T; Ishibiki K; Abe O; Tadakuma T; Yasuda T; Nagaike K; Hosokawa S; Sakaguchi S Gan To Kagaku Ryoho; 1989 Jun; 16(6):2213-7. PubMed ID: 2472119 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of metastatic carcinoma cell growth in livers by poly(I):poly(C)/cationic liposome complex (LIC). Hirabayashi K; Yano J; Takesue H; Fujiwara N; Irimura T Oncol Res; 1999; 11(11-12):497-504. PubMed ID: 10905561 [TBL] [Abstract][Full Text] [Related]
6. The effect of adriamycin against a liver metastatic model by encapsulation in liposomes. Yachi K; Suzuki N; Tanaka N; Okada K; Mitsui I; Kawato Y; Komagata Y; Komiyama K; Kikuchi H Biopharm Drug Dispos; 1996 Nov; 17(8):699-715. PubMed ID: 8950048 [TBL] [Abstract][Full Text] [Related]
7. Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio. Lopez-Barcons LA; Polo D; Llorens A; Reig F; Fabra A Oncol Rep; 2005 Nov; 14(5):1337-43. PubMed ID: 16211306 [TBL] [Abstract][Full Text] [Related]
8. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637 [TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv. Cheng WW; Allen TM J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849 [TBL] [Abstract][Full Text] [Related]
10. [Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein or anti-carcinoembryonic antigen monoclonal antibodies]. Konno H Nihon Geka Gakkai Zasshi; 1986 Apr; 87(4):365-74. PubMed ID: 2423862 [TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of adriamycin entrapped in liposomes conjugated with monoclonal antibody against tumor-associated antigen of bovine leukemia cells. Onuma M; Odawara T; Watarai S; Aida Y; Ochiai K; Syuto B; Matsumoto K; Yasuda T; Fujimoto Y; Izawa H Jpn J Cancer Res; 1986 Nov; 77(11):1161-7. PubMed ID: 3025145 [TBL] [Abstract][Full Text] [Related]
12. [Fundamental studies of targeting cancer chemotherapy against choriocarcinoma--application of liposome]. Tadera S; Yamanaka N; Kamidono S Hinyokika Kiyo; 1989 Feb; 35(2):209-15. PubMed ID: 2735231 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Lopes de Menezes DE; Pilarski LM; Allen TM Cancer Res; 1998 Aug; 58(15):3320-30. PubMed ID: 9699662 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers. Gabizon A; Goren D; Fuks Z; Barenholz Y; Dagan A; Meshorer A Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331 [TBL] [Abstract][Full Text] [Related]
15. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles. Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183 [TBL] [Abstract][Full Text] [Related]
16. [Target therapy by monoclonal antibody against ovarian carcinoma conjugated with liposomes and adriamycin]. Li WJ; Qian HN; Lu WY Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):539-41, 582. PubMed ID: 7842351 [TBL] [Abstract][Full Text] [Related]
17. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates. Allen TM; Mumbengegwi DR; Charrois GJ Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261 [TBL] [Abstract][Full Text] [Related]
18. A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor. He X; Na MH; Kim JS; Lee GY; Park JY; Hoffman AS; Nam JO; Han SE; Sim GY; Oh YK; Kim IS; Lee BH Mol Pharm; 2011 Apr; 8(2):430-8. PubMed ID: 21222482 [TBL] [Abstract][Full Text] [Related]
19. Doxorubicin encapsulated in sterically stabilized liposomes is superior to free drug or drug-containing conventional liposomes at suppressing growth and metastases of human lung tumor xenografts. Sakakibara T; Chen FA; Kida H; Kunieda K; Cuenca RE; Martin FJ; Bankert RB Cancer Res; 1996 Aug; 56(16):3743-6. PubMed ID: 8706018 [TBL] [Abstract][Full Text] [Related]
20. [Experimental study on targeting therapy of human hepatocellular carcinoma in nude mice using adriamycin-anti-transferrin receptor conjugate]. Wang F; Li S; Lin J Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):354-7. PubMed ID: 8697974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]